These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
709 related items for PubMed ID: 12630765
21. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells. Kaplan J, Cook JA, O'Connor M, Zingarelli B. Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259 [Abstract] [Full Text] [Related]
22. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism]. Zhang M, Zou P, Bai M, Tao XN, Jin Y, Guo R. Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1169-72. PubMed ID: 12921638 [Abstract] [Full Text] [Related]
23. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P. Int J Oncol; 2002 Oct 10; 21(4):915-20. PubMed ID: 12239635 [Abstract] [Full Text] [Related]
24. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways. Hunter JG, van Delft MF, Rachubinski RA, Capone JP. J Biol Chem; 2001 Oct 12; 276(41):38297-306. PubMed ID: 11477074 [Abstract] [Full Text] [Related]
25. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase. Ghosh SS, Gehr TW, Ghosh S, Fakhry I, Sica DA, Lyall V, Schoolwerth AC. Kidney Int; 2003 Jul 12; 64(1):52-62. PubMed ID: 12787395 [Abstract] [Full Text] [Related]
26. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS, Chen WC, Bai X, Wang YD. J Dig Dis; 2007 May 12; 8(2):82-8. PubMed ID: 17532820 [Abstract] [Full Text] [Related]
27. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. Xin X, Yang S, Kowalski J, Gerritsen ME. J Biol Chem; 1999 Mar 26; 274(13):9116-21. PubMed ID: 10085162 [Abstract] [Full Text] [Related]
28. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. Nikitakis NG, Siavash H, Hebert C, Reynolds MA, Hamburger AW, Sauk JJ. Br J Cancer; 2002 Dec 02; 87(12):1396-403. PubMed ID: 12454768 [Abstract] [Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Marx N, Schönbeck U, Lazar MA, Libby P, Plutzky J. Circ Res; 1998 Nov 30; 83(11):1097-103. PubMed ID: 9831704 [Abstract] [Full Text] [Related]
30. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. Giri S, Rattan R, Singh AK, Singh I. J Immunol; 2004 Oct 15; 173(8):5196-208. PubMed ID: 15470065 [Abstract] [Full Text] [Related]
31. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M. Hepatology; 2001 May 15; 33(5):1087-97. PubMed ID: 11343236 [Abstract] [Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K. Cancer; 2002 Nov 15; 95(10):2243-51. PubMed ID: 12412180 [Abstract] [Full Text] [Related]
33. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2. Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY. Arthritis Res Ther; 2005 Nov 15; 7(6):R1325-37. PubMed ID: 16277686 [Abstract] [Full Text] [Related]
34. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Calnek DS, Mazzella L, Roser S, Roman J, Hart CM. Arterioscler Thromb Vasc Biol; 2003 Jan 01; 23(1):52-7. PubMed ID: 12524224 [Abstract] [Full Text] [Related]
35. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. Lin TH, Tang CH, Wu K, Fong YC, Yang RS, Fu WM. J Cell Physiol; 2011 Dec 01; 226(12):3242-50. PubMed ID: 21344384 [Abstract] [Full Text] [Related]
36. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Chen ZY, Tseng CC. Mol Pharmacol; 2005 Nov 01; 68(5):1203-13. PubMed ID: 16077033 [Abstract] [Full Text] [Related]
37. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C. FASEB J; 2002 Jul 01; 16(9):1027-40. PubMed ID: 12087064 [Abstract] [Full Text] [Related]
38. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Burgermeister E, Tencer L, Liscovitch M. Oncogene; 2003 Jun 19; 22(25):3888-900. PubMed ID: 12813462 [Abstract] [Full Text] [Related]